Kidney Function Tests Market Size, Share, Growth, and Industry Analysis, By Type (Dilution & Concentration Tests, Clearance Tests, Urine Tests, Imaging Tests), By Application (Hospitals, Diagnostic Laboratories, Academic Research Laboratories), and Regional Insights and Forecast to 2034

•   
•   
  

  Download Free Sample to learn more about this report

    

KIDNEY FUNCTION TESTS MARKET OVERVIEW

The global kidney function tests market size was USD 0.722 billion in 2025 and is projected to touch USD 1.03 billion by 2034, exhibiting a CAGR of 4.1% during the forecast period.

The global kidney function tests market is mainly influenced by a rising number of patients with chronic kidney disease (CKD) that threatens public health, worldwide. Hence, the market is expected to be flooded with demands for creatinine serum, urea, and glomerular filtration rate (GFR) tests, as early diagnosis and treatment of kidney diseases become the most-preferred pathways.

Additionally, the market for kidney function tests gains more drive from technological improvements entailing, among others, point-of-care testing (POCT) devices and molecular diagnostics, which lead to quicker and simpler detection of kidney diseases. There will be a surge of demand for POCT devices due to the convenience, speed, and cost-effectiveness they offer. In addition to that, there will be a surge in demand for digital kidney function testing solutions as these provide remote monitoring and real-time tracking of kidney function. The global kidney function tests market will be at a considerable value by 2028, propelled by the increased demand for kidney function tests and the growing knowledge of patients and healthcare professionals concerning the significance of the early diagnosis and treatment of kidney diseases.

COVID-19 IMPACT

Kidney Function Tests Industry Had a Positive Effect Due to accelerated the adoption of digital healthcare technologies during COVID-19 Pandemic.

Covid-19 had a notable impact on the Kidney Function Tests market share. Indeed, the COVID-19 global challenge had a very strong influence across regions with the market having experienced a demand much higher than expected, and pre-pandemic levels. The abrupt rise in the CAGR reflecting market expansion and demand coming back to pre-pandemic levels is responsible for the recent market surge.

COVID-19 crisis has shaped the kidney function tests market fork in the road, largely resulting in the spiraling of demand for kidney function tests. Healthcare systems scrambled over the globe to manage the different kinds of patients infected with COVID-19. The bulk of the patients, who faced a damaging outcome on kidney health, developed acute kidney injury or exacerbated their previous kidney diseases. Hence, the demand for kidney function tests has spiked to diagnose and monitor these conditions.

On the other hand, the pandemic speeded up the implementation of digital medical care technologies and remote monitoring solutions in the kidney function tests sector. Healthcare providers rapidly adopted telemedicine platforms and remote monitoring systems, both of which can be used to conduct kidney function tests and monitor patients with kidney disease. This ultimately resulted in the reduction of the probability of COVID-19 transmission and the enhancement of the patient’s conditions. Besides, the health crisis was pivotal in the breakthrough of development of portable devices used in point-of-care testing on kidney function. Clinicians were thus able to test patients in facilities fast and without any hassle.

LATEST TRENDS

Growing use of point-of-care (POC) testing devices to Drive Market Growth

The most recent trend fueling the expansion of the kidney function tests market is the growing use of point-of-care (POC) testing devices. This trend is mainly caused by the requirement for timely diagnosis and monitoring of kidney diseases. POC devices give the capability to medical staff to carry out testing in real-time, which also lessens the money and time that are usually needed for laboratory testing. Apart from that, they offer instantaneous results, which in turn allow medical professionals to create treatment plans from well-informed decisions. The POC market will possibly keep on growing, a situation that is largely due to the innovations in the field of technology and the increasing number of people who want a testing method that is not only convenient but also relatively cheap. This trend will reshape the kidney function tests market, making early detection and therapy of renal diseases feasible.

•   
•   
  

  Download Free Sample to learn more about this report

    

KIDNEY FUNCTION TESTS MARKET SEGMENTATION

By Type

Based on Type, the global market can be categorized into Dilution & Concentration Tests, Clearance Tests, Urine Tests, Imaging Tests.

• Dilution & Concentration Tests: Dilution and Concentration Tests are used to evaluate the kidney's ability to concentrate or Dilution and Concentration Tests are done to understand how the kidney makes urine more concentrated or more diluted when the amount of water consumed or hormone secretion changes. Usually, these experiments mean the collection of samples of urine at different periods of the day and the concentration of different solutes such as sodium and urea are determined. In fact, the results may show that the kidneys do not have enough power or that the body is not able to control its fluid balance.

• Clearance Tests: Clearance Tests are concerned with how fast kidneys remove the unwanted materials from the blood, thus, they reveal the filtration and excretion functions of kidneys. The tests mostly use the injecting of a filtered substance by the kidneys and after measuring its quantity in the urine for a certain time, the rate of clearance is calculated. Clearance rates are valuable in diagnosing as well as in treating the stages of kidney diseases.

• Urine Tests: Urine Tests The main purpose of urine tests is to check the presence of proteins, glucose, and blood cells and the like in a person's urine sample to identify potential kidney-related problems. Such procedures may uncover symptoms of kidney damage or infection, and are usually accompanied by other diagnostic means. Urine tests enable either a lab technician to perform them or a dipstick device to be used.

• Imaging Tests: Imaging examinations, including ultrasound, CT, and MRI scans, are methods that enable professionals from the medical field to see not only the renal organs' morphology but also their performance. Commonly, these tests serve to identify the causes of kidney damage as well as signs of disease or obstructions like renal calculi. Moreover, imaging tests can be utilized to observe slowing down or speeding up of kidney disease besides checking the effectiveness of the treatment plan.

By Application

Based on application, the global market can be categorized into Hospitals, Diagnostic Laboratories, Academic Research Laboratories.

• Hospitals: Hospitals incorporate kidney function tests to keep a check on patients suffering from chronic kidney disease, diabetes, or high blood pressure. Such tests used for evaluating the kidneys before any surgical operation or when a patient is being treated with nephrotoxic drugs. The outcomes help in making clinical decisions regarding the management of acute or chronic renal conditions.

• Diagnostic Laboratories: Diagnostic laboratories carry out kidney function tests like serum creatinine, urea, and GFR for the early realization of kidney impairment. They are a source of accurate and standardized results for doctors and patients. These labs are always ready to support the implementation of mass screenings as well as routine health checkups.

• Academic Research Laboratories: Academic research laboratories employ kidney function tests to investigate renal physiology, disease mechanisms, and the effects of drugs on kidney function. They gather and process biochemical data from clinical trials or experimental models. The publications serve as a resource for further developments in nephrology and personalized medicine.

MARKET DYNAMICS

Driving Factors

Rising Prevalence of Chronic Kidney Disease to Boost the Market

A factor in the Kidney Function Tests market growth is the Rising Prevalence of Chronic Kidney Disease. The increasing prevalence of chronic kidney disease is the main reason why the market for "Kidney Function Tests" has expanded. Chronic kidney disease, as a global health issue, affects about 10% of the global population and is on its way to becoming the major cause of death worldwide. As the situation deteriorates, the first necessity is to perform the most accurate and the most reliable kidney function tests and these tests, are in high demand. Chronic kidney disease has been linked to some causes such as an aging population, increasing obesity and diabetes, and hypertension. Consequently, healthcare providers use the kidney function tests to diagnose and treat the disease. Consequently, this rise in the use of kidney function tests is anticipated to continuously drive market growth in the industry of kidney function testing.

Advancements in Diagnostic Technology to Expand the Market

Besides the prevalence of chronic kidney disease, the market for kidney function tests is also being positively affected by innovating diagnostic technology. Quick and easy tests as well as fully automated laboratory analyzers are just some of the new and enhanced diagnostic tools that are facilitating kidney function testing. The innovations are making procedures more straightforward, less expensive, and more accurate, which is why the volume of testing is growing. Physicians can now more effectively diagnose and treat renal disease thanks to the emergence of more biomarkers and molecular diagnostics. This is in line with the trends of the market for kidney function tests that sees rapid growth as providers of healthcare apply new technologies which lead to better patient outcomes. In brief, the growth in the market for kidney function tests is strongly influenced by the widespread availability and adoption of technologically advanced diagnostic tools.

Restraining Factor

High cost of advanced diagnostic technologies to Potentially Impede Market Growth

The elevated expenses of high-tech diagnostic facilities like ultrasounds and MRI machines, whose purpose is to locate and diagnose renal function problems, constitute the major limiting factor of the kidney function test market. These devices cost a lot and might not be readily available in low-income countries, which can thus limit their usage in kidney function disorder diagnosis. The high price can be a barrier to the wide use of such technologies in the different parts of the world. Moreover, the expense of the continual care and the upgrading of these pieces of equipment is also significant which can be a major obstacle to the healthcare providers. Thus the level of accessibility to advanced diagnostic services for patients in these areas can be negatively affected. Consequently, the rate of technology adoption could be slow in the developing world. The high price is the biggest restraining factor in the kidney function test market.

Next-Generation Non-Invasive Diagnostic Solutions to Create Opportunity for the Product in the Market

Opportunity

The market of Kidney Function Tests through the addition of AI-powered, non-invasive sensing technologies is going to be radically changed. Biosensors which can be worn on the body and can monitor real-time kidney function will be disease detectors at early stages and will also pave the way for personalized treatment plans. Also, due to the futuristic method, the whole testing procedure is going to be so easy that there will be fewer painful blood draws and the patients will also willingly undergo the tests.

Based on AI, the analyzing of sensor data will give doctors the necessary insights that can be acted upon facilitating more effective disease management. The expected shift to non-invasive diagnostics will be the major driver of the Kidney Function Tests market expansion. Non-invasive sensing technologies are expected to account for a little over 30% of the worldwide market share by 2030.

Development of non-invasive, real-time monitoring systems Could Be a Potential Challenge for Consumers

Challenge

In the year 2050, the medical world is going to be very different with the introduction of portable, implantable, and AI-powered kidney function test devices. This challenge calls for the creation of innovative, non-invasive, and real-time monitoring systems capable of tracking kidney function, identifying disease early, and giving recommendations for personalized treatment. The device should be small enough for under-the-skin implantation but still, it should be powerful enough to both analyze complex biomarkers and provide precise results.

Moreover, it should also be supported by various wearable technology platforms and be able to integrate perfectly with the electronic health records system. Ultimately, the aim is to come up with a device that is able to transform kidney care and at the same time, increase the number of positive patient outcomes.

•   
•   
  Download Free Sample to learn more about this report

    

KIDNEY FUNCTION TESTS MARKET REGIONAL INSIGHTS

• North America

North America is the fastest-growing region in this market. The United States Kidney Function Tests market has been growing exponentially owing to multiple reasons. The Kidney Function Tests market in North America is mainly supported by the rise in the incidences of chronic kidney disease as well as the increasing demand for point-of-care diagnostics. The region's mature healthcare infrastructure and the presence of reimbursement policies make it easier to adopt advanced diagnostic technologies. Market leaders like Abbott Laboratories and Siemens Healthcare have a strong hold over the market. The United States is the largest contributor to the regional market, with Canada ranking second. An increasing emphasis on personalized medicine and precision diagnostics is likely to serve as a major catalyst for market growth.

• Europe

The market for Kidney function tests in Europe is marked by the domination of regulatory bodies that lead the way in implementing cutting-edge diagnostic technologies. The healthcare industry in the area is moving towards more individualized and precision-based methods, which creates a good market for kidney function tests. The United Kingdom, Germany, and France are the major markets in Europe, supported by an efficient distribution network and a strong demand for diagnostic instruments. The aging population of the region also plays a part in the increasing demand for kidney function tests. Market players such as Roche Diagnostics and bioMérieux are active in the European market.

• Asia

The kidney function test market in the Asia Pacific is booming and that rise is mainly attributed to the increasing incidences of chronic kidney diseases and the fast-developing healthcare infrastructure situation. As a result of the burgeoning demand for diagnostic instruments and the increasing attention on healthcare innovation, China and Japan are the two largest contributors to the regional market. Other factors such as the wide acceptance of point-of-care diagnostics and the growing focus on personalized medicine are fueling the region's market. Moreover, the region's market is also being driven by the presence of such key players as Sysmex and Terumo. Also, the region's market is anticipated to experience substantial growth in the coming years.

KEY INDUSTRY PLAYERS

Key Industry Players Shaping the Market Through Innovation and Market Expansion

Key industry players are shaping the kidney function tests marketplace through strategic innovation and market expansion. These companies are introducing advanced techniques and processes to improve the quality and performance of their offerings. They are also expanding their product lines to include specialized variations, catering to diverse customer preferences. Additionally, they are leveraging digital platforms to increase market reach and enhance distribution efficiency. By investing in research and development, optimizing supply chain operations, and exploring new regional markets, these players are driving growth and setting trends within the kidney function tests.

List Of Top Kidney Function Tests Companies

• Abbott [U.S.]
• bioMérieux [France]
• QIAGEN [Germany]
• Hologic [U.S.]
• Lucigen [U.S.]

KEY INDUSTRY DEVELOPMENT

December 2023: ProNephro AKI (NGAL) by BioPorto is the first biomarker-based diagnostic that has been cleared by the FDA to identify the risk of acute kidney injury (AKI) in patients aged 3 months to 21 years. The test identifies NGAL as a single most direct marker of kidney cell damage, thus, it can detect the injury earlier than the usual serum-creatinine tests. The test, which is meant to be used on Roche cobas c 501 analyzers, is a way of making the clinical decision faster in ICU settings. The introduction of the product is a loud shout of the growing demand for the advanced diagnostics in the assessment of kidney function.

REPORT COVERAGE

SWOT analysis is presented in this work at a high level, and helpful recommendations regarding further evolvement of the market are considered. This paper takes an opportunity to review and discuss the market segments and possible applications that have the potential to influence the market growth in the future years. The kidney function tests with better portability is expected to gain high growth rates due to better consumer adoption trends, increasing application areas, and more innovative product developments. Yet, there might be some problems like, for instance, the shortage of raw materials or higher prices for them. However, the growing popularity of specialized offerings and tendencies towards enhancing quality foster the growth of the market. All of them are progressing through technology and innovative strategies in developments as well as in supply chain and market. Due to changes in the market environment and growing demand for variety, the kidney function tests has a promising development since it constantly develops and expands its application.